EpiGenesis Pharmaceutical, Inc.
3Patents
1Active
3Granted
32Portfolio score
Filing activity: Jun 3, 2003 → Aug 20, 2004 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7456161B2 | Use of DHEA and DHEA-sulfate for the treatment of chronic obstructive pulmonary disease | Human Necessities | 18 | Expired |
| US7405207B2 | Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof | Human Necessities | 10 | Expired |
| US7893044B2 | Composition and method for altering levels of or sensitivity to adenosine with analogs of dehydroepiandrosterone | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.